Lipoglycopeptide Antibacterial [EPC] - N0000191281

Pharmacologic Code	N0000191281
Pharmacologic Name	Lipoglycopeptide Antibacterial
Pharmacologic Uses	lipoglycopeptide antibacterial
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Lipoglycopeptide Antibacterial [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	57970-100	Dalvance	Non-Proprietary Name: Dalbavancin	Injection, Powder, For Solution	Intravenous	Allergan, Inc.	ACTIVE
	66220-315	Vibativ	Non-Proprietary Name: Telavancin Hydrochloride	Injection, Powder, Lyophilized, For Solution	Intravenous	Cumberland Pharmaceuticals Inc.	ACTIVE
	70842-140	Orbactiv	Non-Proprietary Name: Oritavancin	Injection, Powder, Lyophilized, For Solution	Intravenous	Melinta Therapeutics, Llc	ACTIVE
	70842-225	Kimyrsa	Non-Proprietary Name: Oritavancin Diphosphate	Injection, Powder, Lyophilized, For Solution	Intravenous	Melinta Therapeutics, Llc	ACTIVE